BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lim WH, Shingde M, Wong G. Recurrent and de novo Glomerulonephritis After Kidney Transplantation. Front Immunol 2019;10:1944. [PMID: 31475005 DOI: 10.3389/fimmu.2019.01944] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Zanoni F, Khairallah P, Kiryluk K, Batal I. Glomerular Diseases of the Kidney Allograft: Toward a Precision Medicine Approach. Seminars in Nephrology 2022;42:29-43. [DOI: 10.1016/j.semnephrol.2022.01.005] [Reference Citation Analysis]
2 Dashti-Khavidaki S, Saidi R, Lu H. Current status of glucocorticoid usage in solid organ transplantation. World J Transplant 2021; 11(11): 443-465 [PMID: 34868896 DOI: 10.5500/wjt.v11.i11.443] [Reference Citation Analysis]
3 Kwon CS, Daniele P, Forsythe A, Ngai C. A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy. J Health Econ Outcomes Res 2021;8:36-45. [PMID: 34692885 DOI: 10.36469/001c.26129] [Reference Citation Analysis]
4 Rosa-Guerrero P, Leiva-Cepas F, Agüera-Morales M, Navarro-Cabello MD, Rodríguez-Benot A, Torres-De-Rueda A. First Report in the Literature of Biopsy-Proven Noncollapsing Focal Segmental Glomerulosclerosis Relapse in a Second Renal Transplant Presenting With Thrombotic Microangiopathy: A Case Report. Transplant Proc 2021:S0041-1345(21)00627-8. [PMID: 34627595 DOI: 10.1016/j.transproceed.2021.07.056] [Reference Citation Analysis]
5 Heybeli C, Alexander MP, Bentall AJ, Amer H, Buadi FK, Dean PG, Dingli D, Dispenzieri A, El Ters M, Gertz MA, Issa NS, Kapoor P, Kourelis T, Kukla A, Kumar S, Lacy MQ, Lorenz EC, Muchtar E, Murray DL, Nasr SH, Prieto M, Rajkumar SV, Schinstock CA, Stegall MD, Warsame R, Leung N. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series. Am J Kidney Dis 2021:S0272-6386(21)00692-2. [PMID: 34175375 DOI: 10.1053/j.ajkd.2021.04.015] [Reference Citation Analysis]
6 Cruzado Vega L, Santos García A. Single rituximab dose as treatment for membranoproliferative glomerulonephritis relapse after kidney transplant. Nefrología (English Edition) 2021;41:601-3. [DOI: 10.1016/j.nefroe.2021.11.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gallo E, Mingozzi S, Mella A, Fop F, Presta R, Burdese M, Boaglio E, Torazza MC, Giraudi R, Leonardi G, Lavacca A, Gontero P, Sedigh O, Bosio A, Verri A, Dolla C, Biancone L. Clinical outcomes and temporal trends of immunological and non-immunological rare diseases in adult kidney transplant. BMC Nephrol 2021;22:386. [PMID: 34789191 DOI: 10.1186/s12882-021-02571-z] [Reference Citation Analysis]
8 De Souza L, Prunster J, Chan D, Chakera A, Lim WH. Recurrent glomerulonephritis after kidney transplantation: a practical approach. Curr Opin Organ Transplant 2021;26:360-80. [PMID: 34039882 DOI: 10.1097/MOT.0000000000000887] [Reference Citation Analysis]
9 Schena FP, Esposito P, Rossini M. A Narrative Review on C3 Glomerulopathy: A Rare Renal Disease. Int J Mol Sci 2020;21:E525. [PMID: 31947692 DOI: 10.3390/ijms21020525] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Khairallah P, Kamal J, Crew RJ, Serban G, Vasilescu ER, Dube GK, Batal I. The Association Between Post-Kidney Transplant De Novo Glomerulonephritis and Alloimmunity. Kidney Int Rep 2021;6:813-6. [PMID: 33732995 DOI: 10.1016/j.ekir.2020.12.028] [Reference Citation Analysis]
11 Cruzado Vega L, Santos García A. Single rituximab dose as treatment for membranoproliferative glomerulonephritis relapse after kidney transplant. Nefrologia (Engl Ed) 2021:S0211-6995(21)00023-0. [PMID: 33653649 DOI: 10.1016/j.nefro.2020.11.010] [Reference Citation Analysis]
12 Chen CC, Lin WC, Lee CY, Yang CY, Tsai MK. Two-year protocol biopsy after kidney transplantation in clinically stable recipients - a retrospective study. Transpl Int 2021;34:185-93. [PMID: 33152140 DOI: 10.1111/tri.13785] [Reference Citation Analysis]
13 Kwon CS, Daniele P, Forsythe A, Ngai C. A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy. JHEOR 2021;8:36-45. [DOI: 10.36469/jheor.2021.26129] [Reference Citation Analysis]
14 Ravipati P, Jackson S, Tumer G, Nachman PH, Riad SM. Long-Term Outcomes of Kidney Transplant Recipients with Glomerulonephritides by Induction Type and Steroid Avoidance. Transplantology 2022;3:68-82. [DOI: 10.3390/transplantology3010007] [Reference Citation Analysis]
15 Chukwu CA, Middleton R, Kalra PA. Recurrent glomerulonephritis after renal transplantation. Current Opinion in Nephrology & Hypertension 2020;29:636-44. [DOI: 10.1097/mnh.0000000000000643] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]